Kymera Therapeutics Inc.

NASDAQ: KYMR · Real-Time Price · USD
34.63
0.36 (1.05%)
At close: May 01, 2025, 3:59 PM
34.55
-0.25%
After-hours: May 01, 2025, 04:27 PM EDT

Kymera Therapeutics Revenue

Kymera Therapeutics reported an annual revenue of $47.07M, reflecting a -40.11% growth. For the quarter ending December 31, 2024, Kymera Therapeutics generated $7.39M in revenue.
Revenue (ttm)
$47.07M
Revenue Growth
-40.11%
Price / Sales Ratio
64.14
Revenue / Employee
$250.38K
Employees
188
Market Cap
2.25B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 47.07M -40.11%
Dec 31, 2023 78.59M +67.84%
Dec 31, 2022 46.83M -35.71%
Dec 31, 2021 72.83M +114.00%
Dec 31, 2020 34.03M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.